Join the Cirrhosis group to help and get support from people like you.
Cirrhosis News
Random Forest AI Model Superior for Inpatient Mortality Prognostication in Cirrhosis
THURSDAY, July 24, 2025 – For inpatients with cirrhosis, a machine learning (ML) model using random forest (RF) analysis is superior for prediction of inpatient mortality, according to a study...
Metabolic Surgery May Be Beneficial in MASH-Related Cirrhosis, Obesity
MONDAY, Feb. 3, 2025 – For patients with compensated metabolic dysfunction-associated steatohepatitis (MASH)-related cirrhosis and obesity, metabolic surgery is associated with a lower risk for...
Dose-Dependent Link Seen for Alcohol, Cirrhosis, Liver Cancer in Patients With Hep B
WEDNESDAY, Jan. 29, 2025 – For patients with hepatitis B virus, alcohol is associated with dose-dependent increased risks for cirrhosis and hepatocellular carcinoma (HCC), according to a review...
Prevalence of Cirrhosis Higher for Trans- Versus Cisgender Adults
THURSDAY, Dec. 26, 2024 – Trans- versus cisgender adults have an increased prevalence of cirrhosis but similar five-year survival, according to a study published in the December issue of the...
Coronary Artery Disease Common in Patients With Cirrhosis
FRIDAY, Dec. 20, 2024 – Coronary artery disease (CAD) is common in patients with cirrhosis, but cirrhosis itself is not significantly associated with an increased CAD risk, according to a review...
Low Zinc Levels Seen With Liver Cirrhosis, Hepatic Encephalopathy
WEDNESDAY, Nov. 6, 2024 – Serum zinc is often deficient in patients with liver cirrhosis and hepatic encephalopathy (HE), according to a study published online in the September issue of the Journal...
Scientists Successfully Reverse Liver Fibrosis in Mice
FRIDAY, Nov. 1, 2024 – Cirrhosis, hepatitis infection and other causes can trigger liver fibrosis – a potentially lethal stiffening of tissue that, once begun, is irreversible. For many patients, a...
GLP-1 RA Use Linked to Reduced Cirrhosis Risk in MASLD, Diabetes
TUESDAY, Sept. 17, 2024 – For patients with metabolic dysfunction-associated steatotic liver disease (MASLD) and diabetes, glucagon-like peptide 1 receptor agonist (GLP-1 RA) use is associated with...
Stretching, Meditation Cut Muscle Cramp Severity in Cirrhosis Patients
TUESDAY, Aug. 27, 2024 – Stretching and meditation both help reduce muscle cramp severity for individuals with cirrhosis, according to a study published online June 11 in Liver International. Elliot ...
Study Reveals MASLD, MetALD Responsible for One-Third of ICU Cirrhosis Cases
TUESDAY, Aug. 6, 2024 – Metabolic dysfunction-associated steatotic liver disease (MASLD)-related and metabolic and alcohol-related liver disease (MetALD)-related cirrhosis is responsible for...
Prevalence of Cirrhosis Higher in Transgender Versus Cisgender Adults
MONDAY, July 29, 2024 – Transgender adults have higher prevalence of cirrhosis, but they do not have increased incidence of liver-related outcomes or all-cause mortality, according to a study...